Stay updated on BI456906 Safety & Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.

Latest updates to the BI456906 Safety & Efficacy in NASH Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRemoved the term 'Non-alcoholic fatty liver disease' and the related topic 'MedlinePlus Genetics' from the page's related topics.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision: v3.5.0 is now shown, replacing Revision: v3.4.3.SummaryDifference0.0%

- Check29 days agoChange DetectedAdded related topics: 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics'.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check43 days agoChange Detected- Removed references to Non-alcoholic fatty liver disease and related topics: MedlinePlus Genetics from the page. This affects only related topics/keywords and does not alter the core study content.SummaryDifference0.1%

- Check50 days agoChange Detected- Added related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the Related Topics section. This provides contextual background and quick access to related resources for the study.SummaryDifference0.1%

Stay in the know with updates to BI456906 Safety & Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.